Skip to main content
Eisai Co., Ltd. (TYO:4523)
Japan flag Japan · Delayed Price · Currency is JPY
4,821.00
-39.00 (-0.80%)
At close: Mar 9, 2026

Eisai Revenue

Eisai had revenue of 219.94B JPY in the quarter ending December 31, 2025, with 1.76% growth. This brings the company's revenue in the last twelve months to 808.19B, up 2.09% year-over-year. In the fiscal year ending March 31, 2025, Eisai had annual revenue of 789.40B with 6.42% growth.

Revenue (ttm)
808.19B
Revenue Growth
+2.09%
P/S Ratio
1.68
Revenue / Employee
74.03M
Employees
10,917
Market Cap
1,359.00B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025789.40B47.65B6.42%
Mar 31, 2024741.75B-2.65B-0.36%
Mar 31, 2023744.40B-11.82B-1.56%
Mar 31, 2022756.23B110.28B17.07%
Mar 31, 2021645.94B-49.68B-7.14%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sumitomo Pharma 453.40B
Shionogi & 465.38B
Hisamitsu Pharmaceutical Co. 159.27B
Nippon Shinyaku 166.05B
Toho Holdings 1,539.60B
Tsumura & Co. 189.50B
Sawai Group Holdings 200.68B
Takeda Pharmaceutical Company 4,464.58B
Revenue Rankings

Eisai News

More News